Trials / Completed
CompletedNCT01315327
Omega-3 Fatty Acids in Tourette's Disorder
A Double-Blind, Placebo-Controlled Study of Omega-3 Fatty Acids in Children and Adolescents With Tourette's Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.
Detailed description
This is a 20-week, double-blind, placebo (olive oil) controlled study examining supplemental fish oil in the treatment of tic and OCD symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omega-3 Fatty Acids | Omega-3 fatty acids (derived from fish oil) |
| DRUG | Olive oil | Placebo |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2006-02-01
- Completion
- 2012-05-01
- First posted
- 2011-03-15
- Last updated
- 2014-07-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01315327. Inclusion in this directory is not an endorsement.